Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Bill Kelly

UConn researchers record cell communication

Researchers with the University of Connecticut (UConn) School of Dental Medicine developed a technology platform that allows them to record cells communicating in real time....

| By Bill Kelly

SpringWorks in multiple myeloma collaboration

SpringWorks Therapeutics reports that the company has entered into a clinical trial collaboration agreement with GlaxoSmithKline to evaluate SpringWorks Therapeutics’ investigational gamma secretase inhibitor, nirogacestat, in combination...

| By Bill Kelly

Yale researchers investigate metastasis

Yale researchers have discovered how metastasis, or the spread of cancer cells, is triggered on the molecular level. They also developed a way to detect those...

| By Bill Kelly

IsoPlexis receives $4 million grant re IsoLIght

IsoPlexis has received $4 million in grant funding from the National Cancer Institute’s Small Business Innovation Research Development Center as a part of the commercialization...

| By Bill Kelly

Tangen Biosciences closes $9 million Series A

Tangen Biosciences has closed a $9 million Series A equity round led by Connecticut Innovations (CI), with participation of current and new stockholders, including VC23, Axiom,...

| By Bill Kelly

FDA clears Arvinas breast cancer treatment

Arvinas reports that the FDA has cleared the company’s Investigational New Drug application for ARV-471, an oral estrogen receptor PROTAC® protein degrader, designed for treatment of...

| By Bill Kelly

UConn taps into cell communication

A new technology discovered by a team including UConn School of Dental Medicine researchers records cellular communication in real time – providing a closer look...

| By Bill Kelly

Intensity Therapeutics to collaborate with Merck

Intensity Therapeutics reports it has entered into an agreement with Merck (known as MSD outside the United States and Canada), through a subsidiary, to evaluate the...

| By Bill Kelly

UConn alcohol research center continues run

Despite increasing competition for federal research dollars, the Alcohol Research Center at UConn Health endures well into its fifth decade with an unprecedented continuation of...